192 related articles for article (PubMed ID: 17581121)
1. Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.
Bonilla JA; Bonilla TD; Yowell CA; Fujioka H; Dame JB
Mol Microbiol; 2007 Jul; 65(1):64-75. PubMed ID: 17581121
[TBL] [Abstract][Full Text] [Related]
2. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.
Bonilla JA; Moura PA; Bonilla TD; Yowell CA; Fidock DA; Dame JB
Int J Parasitol; 2007 Mar; 37(3-4):317-27. PubMed ID: 17207486
[TBL] [Abstract][Full Text] [Related]
3. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.
Omara-Opyene AL; Moura PA; Sulsona CR; Bonilla JA; Yowell CA; Fujioka H; Fidock DA; Dame JB
J Biol Chem; 2004 Dec; 279(52):54088-96. PubMed ID: 15491999
[TBL] [Abstract][Full Text] [Related]
4. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
5. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura PA; Dame JB; Fidock DA
Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
[TBL] [Abstract][Full Text] [Related]
6. The role of Plasmodium falciparum food vacuole plasmepsins.
Liu J; Gluzman IY; Drew ME; Goldberg DE
J Biol Chem; 2005 Jan; 280(2):1432-7. PubMed ID: 15513918
[TBL] [Abstract][Full Text] [Related]
7. Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.
Savarino A; Cauda R; Cassone A
J Infect Dis; 2005 Apr; 191(8):1381-2; author reply 1382-3. PubMed ID: 15776390
[No Abstract] [Full Text] [Related]
8. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
[TBL] [Abstract][Full Text] [Related]
9. Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man.
Dame JB; Yowell CA; Omara-Opyene L; Carlton JM; Cooper RA; Li T
Mol Biochem Parasitol; 2003 Aug; 130(1):1-12. PubMed ID: 14550891
[TBL] [Abstract][Full Text] [Related]
10. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.
Banerjee R; Liu J; Beatty W; Pelosof L; Klemba M; Goldberg DE
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):990-5. PubMed ID: 11782538
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.
Luker KE; Francis SE; Gluzman IY; Goldberg DE
Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
Muthas D; Nöteberg D; Sabnis YA; Hamelink E; Vrang L; Samuelsson B; Karlén A; Hallberg A
Bioorg Med Chem; 2005 Sep; 13(18):5371-90. PubMed ID: 16054370
[TBL] [Abstract][Full Text] [Related]
14. Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets.
Moon RP; Bur D; Loetscher H; D'Arcy A; Tyas L; Oefner C; Grueninger-Leitch F; Mona D; Rupp K; Dorn A; Matile H; Certa U; Berry C; Kay J; Ridley RG
Adv Exp Med Biol; 1998; 436():397-406. PubMed ID: 9561248
[No Abstract] [Full Text] [Related]
15. Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.
Sonoiki E; Nsanzabana C; Legac J; Sindhe KM; DeRisi J; Rosenthal PJ
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821443
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum.
Klemba M; Beatty W; Gluzman I; Goldberg DE
J Cell Biol; 2004 Jan; 164(1):47-56. PubMed ID: 14709539
[TBL] [Abstract][Full Text] [Related]
17. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
[TBL] [Abstract][Full Text] [Related]
18. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial effects of HIV proteinase inhibitors: common compounds but structurally distinct enzymes.
Wyatt DM; Berry C
J Infect Dis; 2005 Aug; 192(4):705-6. PubMed ID: 16028143
[No Abstract] [Full Text] [Related]
20. Expression and characterisation of plasmepsin I from Plasmodium falciparum.
Moon RP; Tyas L; Certa U; Rupp K; Bur D; Jacquet C; Matile H; Loetscher H; Grueninger-Leitch F; Kay J; Dunn BM; Berry C; Ridley RG
Eur J Biochem; 1997 Mar; 244(2):552-60. PubMed ID: 9119023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
